
- Get in Touch with Us
Last Updated: Apr 25, 2025 | Study Period: 2024-2030
FEXOFENADINE belongs to a class of drugs called antihistamine or anti-allergic. It is primarily used to treat various kinds of allergies. An allergy is an immune system response to foreign elements typically not harmful to your body.
These foreign elements are known as âallergens.â Allergic condition varies from person to person. Some might be allergic to certain foods and seasonal allergies like hay fever. At the same time, others might be allergic to pollen or pet dander.
FEXOFENADINE contains fexofenadine, a non-drowsy antihistamine. It is less likely to make you feel sleepy than some other antihistamines. However, some people still find it makes them feel quite sleepy, which is used to treat allergies as it blocks the effects of a chemical messenger known as histamine, which is naturally involved in allergic reactions.
FEXOFENADINE is widely used to treat hay fever (an allergy caused by pollen or dust), conjunctivitis (red, itchy eye), eczema (dermatitis), hives (red, raised patches or dots), reactions to insect bites and stings and some food allergies.
FEXOFENADINE is known as a non-drowsy antihistamine. It's less likely to make you feel sleepy than some other antihistamines. FEXOFENADINE provides instant relief from allergic reactions and symptoms by blocking histamine action, a substance which causes immune responses & inflammations in the body.
FEXOFENADINE is widely used to treat hay fever (an allergy caused by pollen or dust), conjunctivitis (red, itchy eye), eczema (dermatitis), hives (red, raised patches or dots), reactions to insect bites and stings and some food allergies.
The Global FEXOFENADINE market accounted for $XX Billion in 2023 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2024 to 2030.
Allegra 120 mg Tablet - Allegra 120 mg Tablet belongs to a class of drugs called antihistamine or anti-allergic. It is primarily used to treat various kinds of allergies. An allergy is an immune system response to foreign elements typically not harmful to your body.
These foreign elements are known as âallergens.â Allergic condition varies from person to person. Some might be allergic to certain foods and seasonal allergies like hay fever. At the same time, others might be allergic to pollen or pet dander.
Allegra 120 mg Tablet contains fexofenadine, a non-drowsy antihistamine. It is less likely to make you feel sleepy than some other antihistamines. However, some people still find it makes them feel quite sleepy, which is used to treat allergies as it blocks the effects of a chemical messenger known as histamine, which is naturally involved in allergic reactions.
Allegra 120 mg Tablet is widely used to treat hay fever (an allergy caused by pollen or dust), conjunctivitis (red, itchy eye), eczema (dermatitis), hives (red, raised patches or dots), reactions to insect bites and stings and some food allergies.
Sl no | Topic |
1 | Market Segmentation |
2 | Scope of the report |
3 | Abbreviations |
4 | Research Methodology |
5 | Executive Summary |
6 | Introduction |
7 | Insights from Industry stakeholders |
8 | Cost breakdown of Product by sub-components and average profit margin |
9 | Disruptive innovation in the Industry |
10 | Technology trends in the Industry |
11 | Consumer trends in the industry |
12 | Recent Production Milestones |
13 | Component Manufacturing in US, EU and China |
14 | COVID-19 impact on overall market |
15 | COVID-19 impact on Production of components |
16 | COVID-19 impact on Point of sale |
17 | Market Segmentation, Dynamics and Forecast by Geography, 2024-2030 |
18 | Market Segmentation, Dynamics and Forecast by Product Type, 2024-2030 |
19 | Market Segmentation, Dynamics and Forecast by Application, 2024-2030 |
20 | Market Segmentation, Dynamics and Forecast by End use, 2024-2030 |
21 | Product installation rate by OEM, 2023 |
22 | Incline/Decline in Average B-2-B selling price in past 5 years |
23 | Competition from substitute products |
24 | Gross margin and average profitability of suppliers |
25 | New product development in past 12 months |
26 | M&A in past 12 months |
27 | Growth strategy of leading players |
28 | Market share of vendors, 2023 |
29 | Company Profiles |
30 | Unmet needs and opportunity for new suppliers |
31 | Conclusion |
32 | Appendix |